Money Concepts Capital Corp Vertex Pharmaceuticals Inc Transaction History

Money Concepts Capital Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$273.83 - $305.53 $58,051 - $64,772	212 Added 113.37%	399 $116,000
Q2 2022 Jul 18, 2022	SELL	$234.96 - $292.55 $80,356 - $100,052	-342 Reduced 64.65%	187 $54,000
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $321,944 - $379,450	-1,454 Reduced 73.32%	529 $138,000
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $94,877 - $119,769	536 Added 37.04%	1,983 $435,000
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $299,557 - $349,175	1,447 New	1,447 $311,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Money Concepts Capital Corp with notifications on news.